SCHEMBL18434664

SCHEMBL18434664

Fc1cc2c(c3ncccc13)NSc1ccccc1-2

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ SLC40A1 Q9NP59 15/20 0.55
▸ KDM4E B2RXH2 4/20 0.39
▸ L3MBTL1 Q9Y468 3/20 0.38
▸ MPI P34949 1/20 0.38
▸ MEN1 O00255 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ THRB P10828 1/20 0.36
▸ PKM P14618 1/20 0.36
▸ IDO1 P14902 1/20 0.36
▸ RECQL P46063 1/20 0.36
▸ TDO2 P48775 1/20 0.36
▸ BLM P54132 1/20 0.36
▸ CASP6 P55212 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18434472 0.84 KDM4E (0.39) SLC40A1KDM4EL3MBTL1MPIMEN1
SCHEMBL18434412 0.84 SLC40A1 (0.55) SLC40A1KDM4EL3MBTL1MEN1ALDH1A1
SCHEMBL12475058 0.84 SLC40A1 (0.55) SLC40A1KDM4EL3MBTL1MPIMEN1
SCHEMBL18434406 0.83 SLC40A1 (0.58) SLC40A1KDM4EMEN1KMT2A
SCHEMBL18434326 0.83 SLC40A1 (0.60) SLC40A1KDM4EL3MBTL1MPI
SCHEMBL18434582 0.82 SLC40A1 (0.43) SLC40A1KDM4EL3MBTL1MPIMEN1
SCHEMBL11973692 0.81 SLC40A1 (0.48) SLC40A1
SCHEMBL11973826 0.80 KDM4E (0.46) SLC40A1KDM4EL3MBTL1
SCHEMBL18434707 0.79 SLC40A1 (0.59) SLC40A1KDM4EL3MBTL1MEN1ALDH1A1
SCHEMBL18434680 0.78 SLC40A1 (0.58) SLC40A1KDM4EL3MBTL1MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2675526-B1 NOVEL SULFONAMINOQUINOLINE HEPCIDIN ANTAGONISTS VIFOR (INTERNATIONAL) AG (CH) 2017-02-01 — — EP disclosed
Send feedback